Impact of age over 70 years in the new allocation system on the outcomes of heart transplantation in the US.

United Network for Organ Sharing (UNOS) heart (allograft) function/dysfunction patient survival

Journal

Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240

Informations de publication

Date de publication:
Apr 2024
Historique:
revised: 30 03 2024
received: 11 01 2024
accepted: 02 04 2024
medline: 12 4 2024
pubmed: 12 4 2024
entrez: 12 4 2024
Statut: ppublish

Résumé

United Network for Organ Sharing (UNOS) allocation criteria changed in 2018 to accommodate the increased prevalence of patients on a ventricular assist device as a bridge to heart transplant and prioritize sicker people in anticipation of a heart graft. We aimed to assess the impact of patient age in the new allocation policy on mortality following heart transplantation. Secondary outcomes included the effect of age ≥70 on post-transplant events, including stroke, dialysis, pacemaker, and rejection requiring treatment. The UNOS Registry was queried to identify patients who underwent heart transplants alone in the US between 2000 and 2021. Patients were divided into groups according to their age (over 70 and under 70 years old). Patients aged over 70 were more likely to require dialysis during follow-up, but less likely to experience rejection requiring treatment, compared with patients aged <70. Age ≥70 in the new allocation system was a significant predictor of 1-year mortality (adjusted HR: 1.41; 95% CI: 1.05-1.91; p = .024), but its effect on 5-year mortality was not significant after adjusting for potential confounders (adjusted HR: 1.27; 95% CI:.97-1.66; p = .077). Undergoing transplantation under the new allocation policy vs the old allocation policy was not a significant predictor of mortality in patients over 70 years old. Age ≥70 is a significant predictor of 1-year mortality following heart transplantation, but not at 5 and 10 years; however, the new allocation does not seem to have changed the outcomes for this group of patients.

Sections du résumé

BACKGROUND BACKGROUND
United Network for Organ Sharing (UNOS) allocation criteria changed in 2018 to accommodate the increased prevalence of patients on a ventricular assist device as a bridge to heart transplant and prioritize sicker people in anticipation of a heart graft. We aimed to assess the impact of patient age in the new allocation policy on mortality following heart transplantation. Secondary outcomes included the effect of age ≥70 on post-transplant events, including stroke, dialysis, pacemaker, and rejection requiring treatment.
METHODS METHODS
The UNOS Registry was queried to identify patients who underwent heart transplants alone in the US between 2000 and 2021. Patients were divided into groups according to their age (over 70 and under 70 years old).
RESULTS RESULTS
Patients aged over 70 were more likely to require dialysis during follow-up, but less likely to experience rejection requiring treatment, compared with patients aged <70. Age ≥70 in the new allocation system was a significant predictor of 1-year mortality (adjusted HR: 1.41; 95% CI: 1.05-1.91; p = .024), but its effect on 5-year mortality was not significant after adjusting for potential confounders (adjusted HR: 1.27; 95% CI:.97-1.66; p = .077). Undergoing transplantation under the new allocation policy vs the old allocation policy was not a significant predictor of mortality in patients over 70 years old.
CONCLUSIONS CONCLUSIONS
Age ≥70 is a significant predictor of 1-year mortality following heart transplantation, but not at 5 and 10 years; however, the new allocation does not seem to have changed the outcomes for this group of patients.

Identifiants

pubmed: 38607287
doi: 10.1111/ctr.15317
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e15317

Informations de copyright

© 2024 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Références

Taylor CJ, Ordóñez‐Mena JM, Roalfe AK, et al. Trends in survival after a diagnosis of heart failure in the United Kingdom 2000‐2017: population based cohort study. BMJ. 2019;364:l223.
Truby LK, Rogers JG. Advanced heart failure: epidemiology, diagnosis, and therapeutic approaches. JACC Heart Fail. 2020;8(7):523‐536.
Cogswell R, John R, Estep JD, et al. An early investigation of outcomes with the new 2018 donor heart allocation system in the United States. J Heart Lung Transplant. 2020;39(1):1‐4.
Stevenson LW, Kormos RL, Young JB, Kirklin JK, Hunt SA. Major advantages and critical challenge for the proposed United States heart allocation system. J Heart Lung Transplant. 2016;35(5):547‐549.
Mehra MR, Canter CE, Hannan MM, et al. The 2016 International society for heart lung transplantation listing criteria for heart transplantation: a 10‐year update. J Heart Lung Transplant. 2016;35(1):1‐23.
Rushakoff JA, Kransdorf EP. Heart transplant in older adults. Curr Transplant Rep. 2022;9(1):48‐54.
Thoracic Organ Transplantation Committee U: OPTN/UNOS policy notice proposal to modify the adult heart allocation SystemA (RRB and Committee Review of Exceptions) BEtA. Available from: https://optn.transplant.hrsa.gov/media/2028/thora cic_polic ynotic e_201612.pdf In
Daneshvar D, Czer LS, Phan A, et al. Heart transplantation in patients aged 70 years and older: a two‐decade experience. Transplant Proc. 2011;43(10):3851‐3856.
Morgan JA, John R, Mancini DM, Edwards NM. Should heart transplantation be considered as a treatment option for patients aged 70 years and older? J Thorac Cardiovasc Surg. 2004;127(6):1817‐1819.
Marelli D, Laks H, Kobashigawa JA, et al. Seventeen‐year experience with 1,083 heart transplants at a single institution. Ann Thorac Surg. 2002;74(5):1558‐1566. discussion 1567.
Blanche C, Blanche DA, Kearney B, et al. Heart transplantation in patients seventy years of age and older: a comparative analysis of outcome. J Thorac Cardiovasc Surg. 2001;121(3):532‐541.
Kilic A, Mathier MA, Hickey GW, et al. Evolving trends in adult heart transplant with the 2018 heart allocation policy change. JAMA Cardiol. 2021;6(2):159‐167.
Estep JD, Soltesz E, Cogswell R. The new heart transplant allocation system: early observations and mechanical circulatory support considerations. J Thorac Cardiovasc Surg. 2020 Sep 16: S0022‐5223(20)32638‐6.
Doulamis IP, Gemelli M, Rempakos A, et al. Impact of new allocation system on length of stay following heart transplantation in the United States. Clin Transplant. 2023:e15114.
Jawitz OK, Raman V, Klapper J, Hartwig M, Patel CB, Milano C. Donor and recipient age matching in heart transplantation: analysis of the UNOS Registry. Transpl Int. 2019;32(11):1194‐1202.
Colvin MM, Smith CA, Tullius SG, Goldstein DR. Aging and the immune response to organ transplantation. J Clin Invest. 2017;127(7):2523‐2529.
Colvin MM, Cook JL, Chang PP, et al. Sensitization in heart transplantation: emerging knowledge: a scientific statement from the American heart association. Circulation. 2019;139(12):e553‐e578.
Heinbokel T, Elkhal A, Liu G, Edtinger K, Tullius SG. Immunosenescence and organ transplantation. Transplant Rev (Orlando). 2013;27(3):65‐75.

Auteurs

Marco Gemelli (M)

Department of Cardiac, Thoracic, Vascular and Public Health Sciences, University of Padua, Padua, Italy.

Ilias P Doulamis (IP)

Department of Surgery, Lahey Clinic, Burlington, Massachusetts, USA.

Mariangela Addonizio (M)

Department of Cardiac, Thoracic, Vascular and Public Health Sciences, University of Padua, Padua, Italy.

Aspasia Tzani (A)

Brigham and Women's Hospital Heart and Vascular Center, Harvard Medical School, Boston, Massachusetts, USA.

Athanasios Rempakos (A)

Medical School of Athens, National and Kapodistrian University of Athens, Athens, Greece.

Polydoros Kampaktsis (P)

Division of Cardiology, Columbia University Irving Medical Center, New York City, New York, USA.

Alvise Guariento (A)

Department of Cardiac, Thoracic, Vascular and Public Health Sciences, University of Padua, Padua, Italy.

Ernesto Ruiz Dunque (ER)

Division of Cardiovascular Medicine, Section of Heart failure and Transplantation, University of Iowa, Iowa City, Iowa, USA.

Rabea Asleh (R)

Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota, USA.
Heart Institute, Hadassah University Medical Center, Hebrew University of Jerusalem, Jerusalem, Israel.

Paulino Alvarez (P)

Division of Cardiology, Cleveland Clinic Foundation, Cleveland, Ohio, USA.

Alexandros Briasoulis (A)

Medical School of Athens, National and Kapodistrian University of Athens, Athens, Greece.
Division of Cardiovascular Medicine, Section of Heart failure and Transplantation, University of Iowa, Iowa City, Iowa, USA.

Classifications MeSH